Private equity (PE) firms typically raise capital to establish limited life funds of 10-14 years duration. They use these funds to acquire a portfolio of existing firms. Each portfolio firm is acquired in a transaction which combines capital from the fund with third party debt finance. The debt is secured against portfolio firms’ assets and/or future cash flows. PE […]
Oxstem, an Oxford biotech spin-off focusing on regenerative medicine for age-related diseases, recently raised a record £16.9 million at start-up (Ward, 2016). The money was invested by the local Oxford Sciences Innovation fund and two American venture capital (VC) investors. Why is this important?
Seed and early-stage venture capital were mainly provided by local investors in the past, as entrepreneurial […]